BioRestorative Therapies, Inc. filed a Form D with the Securities and Exchange Commission on 2025-10-09.
BioRestorative Therapies, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 9, 2025. BioRestorative Therapies, Inc. trades on Nasdaq as BRTX; it was formerly Stem Cell Assurance, Inc. The filing reports $1.40M sold. Its industry group is Biotechnology. It names Lance Alstodt (Director, Executive Officer), Francisco Silva (Director, Executive Officer), Robert Kristal (Executive Officer) (SEC Form D, October 9, 2025).
In its own words: “Focused on degenerative disc disease, metabolic disorders, and aesthetic medicine, BioRestorative Therapies develops advanced stem cell-based treatments that unlock the body’s regenerative potential.” (biorestorative.com, checked November 1, 2026)
Is this your company?
Sell to companies like BioRestorative Therapies, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-09 · the record
Pitching, partnering or investing alongside them? See who really runs and owns BioRestorative Therapies, Inc.
Free to see. No signup.
More on the people and the money behind BioRestorative Therapies, Inc., from the filings we hold.
Cova Capital Partners LLC received sales compensation on this raise and on 2 other raises we hold, nearest in date first:
Biotechnology raises by companies based in New York, filed within 90 days of this one, largest first.
Get an email when BioRestorative Therapies, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when BioRestorative Therapies, Inc. raises, hires or launches. No email unless you switch it on.
Watch BioRestorative Therapies, Inc. →Get the full cited report on BioRestorative Therapies, Inc.
What the filing shows about BioRestorative Therapies, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on BioRestorative Therapies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives BioRestorative Therapies, Inc.'s address as 40 Marcus Drive, Suite One, Melville, NY 11747.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on BioRestorative Therapies, Inc. See pricing
BioRestorative Therapies, Inc. is a registered filer with the SEC (CIK 1505497) and has filed since 2025-10-09. 1 filing is on record, the latest on 2025-10-09.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
BioRestorative Therapies, Inc.'s Form D of 2025-10-09 names Lance Alstodt, Francisco Silva, Robert Kristal and 3 more as its officers, directors or promoters.
Its new offerings report $1.40M sold across 1 offering, as its own filings state.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
The amounts shown above exclude the salaries and fees payable to the executive officers and directors in the ordinary course of business.
Lance Alstodt is named as Director and Executive Officer on the Form D that BioRestorative Therapies, Inc. filed with the SEC on 9 October 2025, one of 6 people that filing names.
Francisco Silva is named as Director and Executive Officer on the Form D that BioRestorative Therapies, Inc. filed with the SEC on 9 October 2025, one of 6 people that filing names.
Robert Kristal is named as Executive Officer on the Form D that BioRestorative Therapies, Inc. filed with the SEC on 9 October 2025, one of 6 people that filing names.
David Rosa is named as Director on the Form D that BioRestorative Therapies, Inc. filed with the SEC on 9 October 2025, one of 6 people that filing names.
Patrick Williams is named as Director on the Form D that BioRestorative Therapies, Inc. filed with the SEC on 9 October 2025, one of 6 people that filing names.
Nickolay Kukekov is named as Director on the Form D that BioRestorative Therapies, Inc. filed with the SEC on 9 October 2025, one of 6 people that filing names.
6 people named on the filing — 3 holding an executive role and 3 as directors only.
Named as of the 2025-10-09 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about BioRestorative Therapies, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on BioRestorative Therapies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on BioRestorative Therapies, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist BioRestorative Therapies, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind BioRestorative Therapies, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for BioRestorative Therapies, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/biorestorative-therapies-inc-form-d-25000001